Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Rosiglitazone

Rosiglitazone

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Rosiglitazone

34 trials tracked of Rosiglitazone: 19 in phase 3 or 4.

34Trials tracked
19Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 7 Phase 3 12 Phase 2 8 Phase 1 1 Other / NA 6
  1. Phase 4 Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients Completed
  2. Phase 4 Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride Completed
  3. Phase 4 Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study Completed
  4. Phase 4 Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 Diabetes Completed
  5. Phase 4 Rosiglitazone for Clozapine Induced Glucose Metabolism Impairment Completed
  6. Phase 4 Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone Health Completed
Show 28 more trials
  1. Phase 4 Gene Regulation by Thiazolidinediones Completed
  2. Phase 3 Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease Completed
  3. Phase 3 Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes Completed
  4. Phase 3 Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients Completed
  5. Phase 3 A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone Completed
  6. Phase 3 Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin Completed
  7. Phase 3 Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT) Completed
  8. Phase 3 Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Completed
  9. Phase 3 RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes Completed
  10. Phase 3 A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy With Sulfonyl Urea) -With Placebo Study Completed
  11. Phase 3 An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus Completed
  12. Phase 3 Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052) Completed
  13. Phase 3 A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs Completed
  14. Phase 2 Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease Completed
  15. Phase 2 Rosiglitazone Effect on Mitochondria and Lipoatrophy Completed
  16. Phase 2 A Trial of Rosiglitazone for Ulcerative Colitis Completed
  17. Phase 2 Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease Completed
  18. Phase 2 The Use of Rosiglitazone to Treat Asthma Completed
  19. Phase 2 Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance Completed
  20. Phase 2 The Effect of Glitazone Treatment on Bone Marrow and Bone Marrow Cells Completed
  21. Phase 2 Effect of Rosiglitazone on the Vascular Biology of Human Fat Tissue Completed
  22. Phase 1 A Study of Pharmacokinetic Drug Interaction Study of the Hedgehog Pathway Inhibitor GDC-0449 in Combination With Rosiglitazone or Combined Oral Contraceptive in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists Completed
  23. N/A Insulin Resistance in Patients With Mood Disorder Completed
  24. N/A Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy Completed
  25. N/A Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth Completed
  26. N/A Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM Completed
  27. N/A Preferred Treatment of Type 1.5 Diabetes Completed
  28. N/A Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides. Completed

Showing the 34 most-cited and recently-updated of 34 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.